| 前收市價 | 201.99 |
| 開市 | 201.21 |
| 買盤 | 202.43 x 300 |
| 賣出價 | 202.54 x 100 |
| 今日波幅 | 198.11 - 205.36 |
| 52 週波幅 | 189.44 - 319.76 |
| 成交量 | |
| 平均成交量 | 1,260,329 |
| 市值 | 29.478B |
| Beta 值 (5 年，每月) | -0.01 |
| 市盈率 (最近 12 個月) | 25.31 |
| 每股盈利 (最近 12 個月) | 8.00 |
| 業績公佈日 | 2024年7月23日 - 2024年7月29日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 287.48 |
ZacksBiotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
Insider MonkeyBiogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 Biogen Inc. misses on earnings expectations. Reported EPS is $3.3 EPS, expectations were $3.45. BIIB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Jennifer, […]
Investor's Business DailyIs Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
